2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with nms p715 in 1 studies
| Studies (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Trials (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Recent Studies (post-2010) (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Studies (nms p715) | Trials (nms p715) | Recent Studies (post-2010) (nms p715) |
|---|---|---|---|---|---|
| 85 | 0 | 62 | 7 | 0 | 7 |
| Protein | Taxonomy | 2-(4-morpholinoanilino)-6-cyclohexylaminopurine (IC50) | nms p715 (IC50) |
|---|---|---|---|
| Dual specificity protein kinase TTK | Homo sapiens (human) | 0.1078 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, M; Li, C; Li, J; Liang, D; Liu, J; Sun, W; Wang, S; Yang, X; Zhang, C; Zhang, M; Zhou, X | 1 |
1 review(s) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and nms p715
| Article | Year |
|---|---|
Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Drug Resistance; Humans; M Phase Cell Cycle Checkpoints; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Spindle Apparatus; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |